unlik
autom
standard
clinic
chemistri
hematolog
laboratori
major
chang
methodolog
oper
clinic
microbiolog
laboratori
sinc
test
associ
antibacteri
suscept
although
tissu
cultur
techniqu
introduc
diagnost
virolog
applic
gener
limit
larg
public
health
laboratori
howev
develop
newer
simpler
rapid
method
scienc
chang
reflect
evolv
technolog
differ
prioriti
variou
healthcar
set
scienc
pf
antivir
chemotherapi
advanc
like
prioriti
come
better
focu
hospit
move
toward
standard
approach
viral
ill
diagnost
laboratori
number
clinic
situat
viral
diagnosi
may
particularli
help
includ
viral
diseas
import
public
health
consider
eg
influenza
arboviru
enceph
viral
diseas
signific
risk
suscept
person
expos
patient
eg
measl
hepat
b
varicella
situat
involv
import
prognost
consider
eg
congenit
infect
enceph
infect
immunocompromis
host
situat
withdraw
antibiot
might
serv
patient
interest
eg
respiratori
viru
infect
viral
mening
situat
therapeut
action
depend
viral
diagnosi
eg
treatment
antivir
agent
hospit
infect
control
therapeut
abort
rubella
pregnanc
case
viral
diagnosi
teach
medic
staff
import
lesson
diseas
epidemiolog
improv
subsequ
care
similar
patient
order
identifi
rang
suspect
virus
one
individu
patient
onu
clinician
provid
comprehens
inform
andor
liais
laboratori
staff
difficult
overemphas
import
collect
proper
clinic
specimen
viral
laboratori
diagnost
unless
clinician
pay
close
attent
detail
time
collect
handl
laboratori
littl
help
acut
viral
ill
specimen
obtain
earli
ill
ie
first
day
symptom
like
contain
recover
viru
specimen
collect
steril
implement
quickli
transport
laboratori
delay
mean
loss
viru
particl
addit
heat
labil
mani
virus
withstand
dri
swab
mucos
surfac
skin
scrape
tissu
place
transport
medium
contain
protein
buffer
neutral
ph
antibiot
kill
suppress
growth
bacteria
fungi
virus
vari
abil
surviv
ambient
temperatur
specimen
viru
isol
alway
transport
diagnost
laboratori
ice
unless
delay
day
anticip
specimen
held
c
frozen
specimen
frozen
kept
c
sinc
convent
freezer
temperatur
c
c
detriment
infect
mani
virus
site
specimen
collect
correl
clinic
present
local
epidemiolog
pattern
howev
deep
gener
diseas
eg
nonvesicular
rash
mening
fever
unknown
origin
congenit
infect
advis
sampl
multipl
site
tabl
show
gener
list
syndrom
common
etiolog
agent
appropri
specimen
gold
standard
viral
isol
viral
cultur
virus
intracellular
parasit
requir
live
cell
order
replic
clinic
laboratori
live
cell
provid
form
suckl
mice
embryon
chicken
egg
cell
cultur
today
clinic
laboratori
prefer
use
cell
cultur
rather
mous
egg
inocul
viru
identif
depend
viral
entri
prolifer
cell
grown
monolay
steril
tissu
cultur
condit
cytopath
effect
cpe
pattern
cell
destruct
result
viral
infect
occur
characterist
pattern
depend
cell
line
infect
viru
member
orthomyxoviru
influenza
viru
paramyxoviru
parainfluenza
viru
mump
group
may
fail
produc
clearcut
cpe
infect
cell
cultur
may
detect
first
sometim
exclus
demonstr
phenomenon
hemabsorpt
virus
produc
hemagglutinin
molecul
protrud
lipid
bilay
recent
advanc
viral
cultur
methodolog
involv
centrifug
patient
specimen
onto
cell
monolay
bottom
glass
shell
vial
period
cultiv
stain
viral
antigen
cell
use
label
monoclon
polyclon
antibodi
centrifug
step
shorten
time
develop
viral
antigen
cpe
monoclon
antibodi
direct
viral
antigen
produc
earli
replic
cycl
detect
viru
even
develop
cpe
exampl
use
shell
vial
techniqu
laboratori
enabl
detect
cytomegaloviru
cmv
posit
specimen
within
h
cumul
total
within
h
remain
detect
tradit
viral
cpe
requir
mean
day
posit
result
techniqu
appli
rapid
detect
sever
virus
includ
herp
simplex
measl
adenoviru
influenza
parainfluenza
respiratori
syncyti
viru
rsv
varicellazost
virus
sameday
diagnosi
wave
futur
microbi
diagnost
howev
rapid
diagnosi
direct
approach
requir
prior
consider
viru
suspect
viral
isol
contrast
openend
approach
may
yield
interest
unanticip
result
analysi
viral
cytopatholog
oldest
form
rapid
diagnosi
exampl
form
test
tzank
prepar
use
diagnos
herp
viru
infect
techniqu
perform
scrape
base
skin
vesicl
transfer
scrape
microscop
slide
slide
allow
air
dri
stain
giemsa
wright
papanicola
stain
slide
view
standard
microscop
find
multinucl
giant
cell
diagnost
herpesviru
infect
method
larg
supersed
fluoresc
antibodi
stain
antigen
detect
method
sensit
also
identifi
specif
herp
viru
present
electron
microscopi
em
use
mani
year
rapid
detect
virus
clinic
specimen
techniqu
reli
identif
virus
characterist
morpholog
one
limit
em
viru
must
present
suffici
quantiti
approxim
particlesml
order
detect
potent
use
lie
detect
virus
fecal
content
em
use
wide
routin
diagnosi
expens
cumbersom
insensit
newer
rapid
test
avail
virus
previous
diagnos
em
immunofluoresc
use
rapid
diagnosi
respiratori
tract
infect
vesicular
exanthem
examin
tissu
method
rapid
precis
sensit
care
attent
paid
techniqu
obtain
process
specimen
use
appropri
control
welltrain
laboratori
staff
interpret
result
clinic
specimen
appli
slide
dri
fix
stain
fluoresc
microscop
use
read
slide
either
fluoresc
organ
infect
cell
stain
may
direct
use
specif
antimicrobi
antibodi
attach
fluoresc
dye
indirect
use
unlabel
specif
antimicrobi
antibodi
follow
fluoresceinlabel
antibodi
direct
initi
antibodi
indirect
test
may
sensit
direct
test
although
recent
studi
suggest
sensit
compar
rsv
measl
sensit
exce
cell
cultur
other
particularli
highqual
reagent
avail
sensit
appear
somewhat
lower
immunofluoresc
also
success
use
detect
distinguish
herp
simplex
varicellazost
virus
vesicl
fluid
method
also
use
examin
tissu
specimen
techniqu
prefer
method
rapidli
diagnos
herp
simplex
enceph
brain
biopsi
b
rabi
anim
brain
immunofluoresc
follow
advantag
one
prepar
slide
stain
number
differ
organ
singl
time
adequaci
specimen
determin
slide
may
made
sent
refer
laboratori
read
enzym
immunoassay
eia
enzymelink
immunosorb
assay
util
multipl
antigenantibodi
reaction
detect
low
concentr
microbi
antigen
eia
avail
diagnosi
respiratori
virus
rsv
influenza
parainfluenza
adenoviru
metapneumoviru
enter
virus
rotaviru
noroviru
adenoviru
herp
simplex
viru
major
advantag
eia
eas
interpret
object
abil
detect
antigen
specimen
collect
handl
manner
disrupt
intact
infect
cell
need
assay
autom
advantag
eia
includ
potenti
nonspecif
reaction
may
give
falseposit
result
abil
test
identifi
presenc
one
infecti
agent
unlik
presenc
one
sever
agent
determin
singl
specimen
one
procedur
recent
advanc
molecular
clone
made
hybrid
possibl
avail
larg
quantiti
clone
viral
dna
use
nucleic
acid
hybrid
becom
practic
possibl
detect
certain
virus
clinic
specimen
hybrid
assay
avail
direct
detect
herp
simplex
viru
cmv
human
papillomaviru
probe
hepat
b
core
surfac
antigen
gene
human
immunodefici
viru
hiv
epsteinbarr
viru
ebv
adenoviru
type
rotaviru
current
avail
polymeras
chain
reaction
pcr
sensit
method
reveal
presenc
otherwis
undetect
quantiti
genom
rna
dna
human
virus
pcr
power
new
techniqu
develop
altern
direct
hybrid
method
use
amplifi
small
piec
viral
dna
rna
clinic
specimen
millionfold
allow
detect
small
quantiti
infecti
agent
singl
sampl
pcr
sensit
detect
ten
infect
cell
one
viru
mani
one
million
cell
clinic
specimen
pcr
sensit
slight
contamin
laboratori
specimen
stray
dna
lead
amplif
dna
origin
specimen
use
current
detect
hiv
herpesvirus
influenza
viru
hepat
virus
rotaviru
ebv
cmv
parvoviru
use
pcr
diagnosi
cn
diseas
well
evalu
hsv
enceph
enteroviru
mening
use
highli
sensit
techniqu
increas
understand
etiolog
role
virus
cn
diseas
exampl
demonstr
varicellazost
viru
vzv
hsv
type
caus
meningit
symptom
without
caus
concurr
skin
lesion
multiplex
pcr
newer
diagnost
technolog
allow
test
multipl
virus
simultan
high
specif
sensit
xtag
rvp
assay
luminex
molecular
diagnost
toronto
canada
one
exampl
approv
us
food
drug
administr
fda
test
detect
differ
virus
sensit
specif
multiplex
pcr
also
avail
diagnosi
csf
enter
virus
viral
genom
quantif
vl
within
year
becom
integr
part
clinic
manag
patient
suffer
infect
hiv
hbv
hcv
human
cmv
besid
provid
prognost
inform
individu
case
particularli
hiv
human
cmv
genom
quantif
play
import
role
monitor
patient
respons
antivir
treatment
vl
test
assess
success
antivir
therapi
includ
unabl
distinguish
differ
factor
involv
includ
treatment
failur
due
viral
develop
antivir
resist
host
factor
one
noncompli
sever
studi
proven
valu
vl
determin
surrog
marker
clinic
marker
therapeut
success
increas
avail
clinic
use
potent
anti
retro
viral
chemotherapi
spark
develop
varieti
commerci
assay
viral
genom
quantif
use
current
detect
hiv
use
research
laboratori
identifi
virus
herpesvirus
influenza
viru
hepat
virus
rotaviru
ebv
cmv
parvoviru
dna
microarray
test
far
avail
research
set
newer
technolog
design
much
broaderspectrum
viral
detect
microchip
approxim
oligonucleotid
probe
repres
fulli
partial
sequenc
virus
detect
known
virus
well
possibl
novel
virus
relat
known
viral
famili
without
priori
knowledg
whole
nucleotid
sequenc
panvir
microarray
use
part
global
effort
identifi
sever
acut
respiratori
syndromeassoci
coronaviru
method
address
problem
associ
earlier
method
reduc
detect
time
less
min
base
rapid
hybrid
enzymat
amplif
use
affect
impur
sampl
present
detect
copi
infecti
agent
per
sampl
adapt
type
sampl
blood
stool
tissu
size
chip
less
cm
activ
site
less
mm
one
classic
method
diagnos
viral
infect
detect
virusspecif
antibodi
antigen
serum
assay
radioimmunoassay
eia
western
blot
protein
electrophores
gel
separ
molecul
accord
size
blot
onto
membran
hybrid
antibodi
specif
protein
interest
measur
antigenantibodi
interact
assay
complement
fixat
latex
agglutin
immun
adher
hemagglutin
depend
capac
antibodi
upon
interact
antigen
perform
nonvirusrel
function
acut
primari
viral
infect
induc
depend
rise
antivir
immunoglobulin
g
antibodi
diagnosi
made
measur
antibodi
level
pair
sera
obtain
earli
cours
diseas
acut
late
recoveri
convalesc
day
later
except
involv
follow
situat
infect
immunodefici
host
form
antibodi
includ
certain
young
infant
superfici
infect
respiratori
infect
may
occasion
fail
induc
antibodi
respons
despit
signific
ill
eg
rsv
infant
regardless
method
employ
serolog
demonstr
antibodi
respons
may
provid
evid
infect
absenc
viru
isol
cultur
unfortun
document
infect
delay
need
assess
convalesc
serum
antibodi
limit
multipl
virus
infect
human
acut
infect
acquir
presenc
passiv
transfer
antibodi
eg
neonat
acquir
cmv
infect
recent
serolog
diagnosi
emphas
detect
specif
immunoglobulin
igm
antibodi
allow
diagnosi
made
singl
specimen
obtain
earli
ill
specif
igm
antibodi
test
use
diseas
suffici
long
incub
period
specif
igm
antibodi
present
time
clinic
present
current
method
choic
diagnosi
rubella
measl
hepat
viru
number
arboviru
infect
continu
technic
problem
mani
igm
assay
includ
interfer
rheumatoid
factor
need
absorb
serum
recent
igg
avid
assay
measur
antibodi
matur
shown
reliabl
discrimin
acut
past
infect
thu
recent
acut
infect
bodi
produc
lowavid
igg
month
bodi
begin
produc
highavid
igg
exampl
low
cmv
igg
avid
suggest
acut
cmv
infect
occur
within
past
month
high
cmv
igg
avid
suggest
cmv
infect
occur
point
past
demonstr
case
cmv
toxoplasma
rubella
avid
indic
less
consid
lowavid
indic
sever
infect
test
acut
convalesc
specimen
identif
virusspecif
igm
antibodi
necessari
infect
typic
chronic
detect
virusspecif
antibodi
often
signifi
current
infect
exampl
includ
hiv
human
lymphotrop
tcell
viru
hepat
c
viru
detect
technolog
continu
evolv
allow
faster
sensit
less
extens
method
pathogen
discoveri
multiplex
pcr
assay
alreadi
wide
implement
microarray
technolog
less
advanc
